| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Investments at fair value-Investment Unaffiliated Issuer | 1,934,475 | - | ||
| Investments at fair value-Investment Affiliated Issuer Noncontrolled | 15,158 | - | ||
| Investments at fair value-Investment Affiliated Issuer Controlled | 584,465 | - | ||
| Cash and cash equivalents | 40,874 | - | ||
| Foreign cash (cost of 18,858 and 2,640, respectively) | 19,730 | - | ||
| Restricted cash and cash equivalents | 26,168 | - | ||
| Collateral on derivatives | 11,110 | - | ||
| Deferred financing costs | 3,807 | - | ||
| Interest receivable on investments | 37,241 | - | ||
| Receivable for sales and paydowns of investments | 29,162 | - | ||
| Prepaid insurance | 727 | - | ||
| Unrealized appreciation on forward currency exchange contracts | 0 | - | ||
| Dividend receivable | 4,057 | - | ||
| Total assets | 2,716,036 | 2,774,306 | ||
| Total net assets | 1,128,547 | 1,139,035 | ||
| Total liabilities and total net assets | 2,716,036 | 2,774,306 | ||
Bain Capital Specialty Finance, Inc. (BCSF)
Bain Capital Specialty Finance, Inc. (BCSF)